Dr. Fang is a consultant in Clinical Operations and Regulatory Affairs with more than 15 years of experience in the pharmaceutical industry. Prior to that, she was on the faculty in Pediatric Gastroenterology, Hepatology and Nutrition at the University of Florida. After entering the pharmaceutical industry, she served as the project lead in the successful application of PEG-Intron for the treatment of chronic hepatitis C in the US and EU and subsequently took on positions as Head of Clinical Development and Regulatory Affairs for a number of pharmaceutical and biotechnology companies. Dr. Fang was instrumental in the filing of numerous INDs, liaising with health authorities, planning of clinical programs and overseeing clinical trials from Phase 1 to Phase 3.